Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2016-08-31
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIV
NCT06001814
A Mindfulness Based Approach to HIV Treatment Side Effects
NCT00312936
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b
NCT05352061
mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV
NCT05046392
Mindfulness Meditation Training in HIV
NCT00600561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fifty participants will be enrolled in this parallel-group randomized clinical trial (RCT). Outpatients recruited from an HIV treatment clinic will be randomized (1:1 ratio) to either MT or to health coaching intervention; both interventions will be administered during 8 weekly phone calls. ART adherence (self-reported measure and unannounced phone pill counts), sexual behavior (self-reports and biomarkers), mindfulness, depression, stress, and impulsivity will be measured at baseline, post-intervention, and 3 months post-intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mindfulness training (MT)
Eight, 30-minute phone delivered MT sessions once a week for 8 weeks
Mindfulness Training (MT)
Participants assigned to the MT condition will receive a phone-delivered 30-minute mindfulness training once a week for 8 weeks. ). In addition to the weekly training session, participants will be instructed to practice mindfulness techniques for 15 minutes daily using a standardized audio recording to guide the participant through the techniques learned with the instructor.
Health Coaching (HC)
Eight, 30-minute phone delivered HC sessions once a week for 8 weeks
Health Coaching (HC)
The HC condition will consist of educational modules designed to control for the contact time and attention received in the MT condition. To match the time MT participants will spend doing mindfulness exercises at home, HC participants will be assigned a 15-minute daily activity that is aligned with the HC topics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness Training (MT)
Participants assigned to the MT condition will receive a phone-delivered 30-minute mindfulness training once a week for 8 weeks. ). In addition to the weekly training session, participants will be instructed to practice mindfulness techniques for 15 minutes daily using a standardized audio recording to guide the participant through the techniques learned with the instructor.
Health Coaching (HC)
The HC condition will consist of educational modules designed to control for the contact time and attention received in the MT condition. To match the time MT participants will spend doing mindfulness exercises at home, HC participants will be assigned a 15-minute daily activity that is aligned with the HC topics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sub-optimal adherence to ART (Less than "always" taking ART medication and/or viral load \> 20 copies/mL);
* Psychological distress (PHQ-4 score ≥ 2);
* Recent risky sexual behavior (any unprotected sex OR \> 1 sexual partner over the past 6 months)
* Access to a telephone or cell phone
Exclusion Criteria
* Cognitive impairment
* Non-English speaking
* Low literacy (i.e., reporting they "often" or "always" need someone to read instructions, pamphlets, or other written material from a doctor or pharmacy to them
* Enrolled in another behavioral trials
* Prior formal mindfulness training or have practiced of mindfulness or related mind-body techniques in the previous year
* Severe hearing impairment not allowing phone delivery
* Suicidal ideation
* Planning to move out of the area within the study period
* Clinic provider advising against recruitment in the study.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
The Miriam Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael P. Carey
Professor and Director, Centers for Preventive and Behavioral Medicine, The Miriam Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MIchael P Carey, PhD
Role: PRINCIPAL_INVESTIGATOR
Centers for Behavioral and Preventive Medicine, The Miriam Hospital
Elena Salmoirago-Blotcher, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Centers for Behavioral and Preventive Medicine, The Miriam Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Miriam Hospital
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.